BEST UNLIMITED TURBO LONG CERTIFICATE - SANOFI Stock

Certificat

8A66S

DE000CL7FXJ9

Real-time Euronext Paris 10:08:58 2024-04-29 am EDT
1.605 EUR +6.29% Intraday chart for BEST UNLIMITED TURBO LONG CERTIFICATE - SANOFI
Current month+0.33%
1 month-4.73%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Chart SANOFI
Chart BEST UNLIMITED TURBO LONG CERTIFICATE - SANOFI
Date Price Change Volume
24-04-29 1.605 +6.29% 2 000
24-04-26 1.51 -3.82% 76
24-04-25 1.57 +34.76% 2,800
24-04-24 1.165 -9.69% 64
24-04-23 1.29 +4.88% 1,500

Real-time Euronext Paris

Last update April 29, 2024 at 10:08 am EDT

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying SANOFI
IssuerLogo Issuer Société Générale Société Générale
8A66S
ISINDE000CL7FXJ9
Date issued 2020-04-06
Strike 76.74
Maturity Unlimited
Parity 10 : 1
Emission price 0.89
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 3.475
Lowest since issue 0.3
Spread 0.01
Spread %0.62%

Company Profile

Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows: - pharmaceutical products (70.6%): prescription drugs in the areas of specialty medicine (59.3% of net sales; for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases) and general medicine (40.7%; mainly for the treatment of diabetes and cardiovascular diseases); - human vaccines (17.4%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas; - consumer health products (12%). At the end of 2023, the group had 54 production sites throughout the world. Net sales are distributed geographically as follows: France (5.5%), Europe (18.6%), the United States (43%), North America (1.6%) and other (31.3%).
Sector
-
More about the company

Ratings for Sanofi

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: Sanofi

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
91.23 EUR
Average target price
108.1 EUR
Spread / Average Target
+18.45%
Consensus
  1. Stock Market
  2. Certificates
  3. 8A66S Certificat